Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Nutraceuticals
  4. Volume 2, Issue 1
  5. Article
Volume 2, Issue 1
  • ISSN: 2665-9786
  • E-ISSN: 2665-9794

Abstract

Natural products are commonly used for treating health problems. These products may be associated with adverse events, which are defined as “noxious and unintended response to a medicinal product” by the European Medicine Agency.

To identify studies describing at least one adverse event (or with potential to promote an adverse event) related to the use of natural products, as well as to describe the involved product(s) and adverse event(s).

A pre-systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. Keywords: “natural product(s)” and [“adverse drug reaction(s)” or “adverse effect(s)”]. Screened databases: and . Inclusion criteria: Papers describing at least one adverse event associated with the use of natural products and published between 2017 and 2019. Exclusion criteria: Repeated studies, reviews and papers written in other languages than English, Portuguese, French or Spanish.

104 studies were identified (20 ; 0 ; 2 ; 82 ), but only 10 were selected (4 and 6 ): 1 study; 2 non-clinical studies, 1 study reporting and clinical data and 5 case reports. Globally, 997 reports of adverse drug reactions with natural products were identified, mainly non-severe cases.

Since a limited number of studies was found, we conclude that adverse events due to natural products may be underreported or natural products may have a good safety profile. This review contributes to assuring the safety of natural products consumers by evaluating the knowledge/information on the potential adverse events and interactions of these products.

© 2021 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnt/10.2174/2665978601999200702163914
2021-03-01
2024-12-23

  • From This Site

    /content/journals/cnt/10.2174/2665978601999200702163914
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Natural products. Avaialbele at:https://www.nature.com/subjects/natural-products(Accessed on January 11, 2020).
     [Google Scholar]
  2. CalixtoJ.B. The role of natural products in modern drug discovery.An. Acad. Bras. Cienc.201991Suppl. 3e2019010510.1590/0001‑376520192019010531166478
     [Google Scholar]
  3. StrohlW.R. StrohlW.R. The role of natural products in a modern drug discovery program.Drug Discov. Today200052394110.1016/S1359‑6446(99)01443‑910652450
     [Google Scholar]
  4. DiasD.A. UrbanS. RoessnerU. A historical overview of natural products in drug discovery.Metabolites20122230333610.3390/metabo202030324957513
     [Google Scholar]
  5. European Commission. Nutrition beyond the trends: Science for Environment Policy THEMATIC ISSUE: Biodiversity, agriculture and health, 2013. Available at:https://ec.europa.eu/environment/integration/research/newsalert/pdf/36si_en.pdf(Accessed on January 11, 2020).
  6. AndrewsL. RalstonS. BlommeE. BarnhartK. A snapshot of biologic drug development: Challenges and opportunities.Hum. Exp. Toxicol.201534121279128510.1177/096032711560359426614816
     [Google Scholar]
  7. YehB.J. LimW.A. Synthetic biology: Lessons from the history of synthetic organic chemistry.Nat. Chem. Biol.20073952152510.1038/nchembio0907‑52117710092
     [Google Scholar]
  8. European Medicine Agency. Guideline on good pharmacovigilance practices (GVP). Annex I: Definitions, Rev4, 2017. Available athttps://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-annex-i-definitions-rev-4_en.pdf (Accessed on January 11, 2020).
  9. European Medicine Agency. 2018 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission, 2019. Available at:https://www.ema.europa.eu/en/documents/report/2018-annual-report-eudravigilance-european-parliament-council-commission-reporting-period-1-january_en.pdfAccessed on January 11, 2020).
     [Google Scholar]
  10. Food and Drug Administration Preventable Adverse Drug Reactions: A Focus on Drug Interactions2018Available at:https://www.fda.gov/drugs/drug-interactions-labeling/preventable-adverse-drug-reactions-focus-drug-interactions#ADRs:%20Prevalence%20and%20Incidence(Accessed on January 11, 2020).
     [Google Scholar]
  11. GellerA.I. ShehabN. WeidleN.J. LovegroveM.C. WolpertB.J. TimboB.B. MozerskyR.P. BudnitzD.S. Emergency Department Visits for Adverse Events Related to Dietary Supplements.N. Engl. J. Med.2015373161531154010.1056/NEJMsa150426726465986
     [Google Scholar]
  12. HuangY.L. MoonJ. SegalJ.B. A comparison of active adverse event surveillance systems worldwide.Drug Saf.201437858159610.1007/s40264‑014‑0194‑325022829
     [Google Scholar]
  13. ElshafieS. ZaghloulI. RobertiA.M. Pharmacovigilance in developing countries (part I): Importance and challenges.Int. J. Clin. Pharm.201840475876310.1007/s11096‑017‑0570‑z29248988
     [Google Scholar]
  14. World Health Organization Members of the WHO Programme for International Drug Monitoring2020Available at:https://www.who-umc.org/global-pharmacovigilance/members/who-programme-members/(Accessed on January 11, 2020).
     [Google Scholar]
  15. TewariD. RawatP. SinghP.K. Adverse drug reactions of anticancer drugs derived from natural sources.Food Chem. Toxicol.201912352253510.1016/j.fct.2018.11.04130471312
     [Google Scholar]
  16. PRISMA PRISMA. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), 2020. Available at:http://www.prisma-statement.org/(Accessed on January 12, 2020).
     [Google Scholar]
  17. PubMed PubMed. PubMed.gov US National Library of Medicine National Institutes of Health, 2020https://www.ncbi.nlm.nih.gov/pubmed/
     [Google Scholar]
  18. ciELO. Scientific Electronic Library Online, 2020.Available at:https://analytics.scielo.org/ (Accessed on January 12, 2020).
  19. DOAJ Directory of Open Access Journals Online2020https://analytics.scielo.org/
     [Google Scholar]
  20. KhabsaM. GilesC.L. The number of scholarly documents on the public web.PLoS One201495e9394910.1371/journal.pone.009394924817403
     [Google Scholar]
  21. CDSR CDSR. Cochrane Database of Systematic Reviews, 2020. Available at: https://www.cochranelibrary.com/cdsr/reviews(Accessed on January 19, 2020).
     [Google Scholar]
  22. PickingD. ChambersB. BarkerJ. ShahI. PorterR. NaughtonD.P. DelgodaR. Inhibition of cytochrome P450 activities by extracts of hyptis verticillata Jacq.: Assessment for potential HERB-drug interactions.Molecules201823243010.3390/molecules2302043029462868
     [Google Scholar]
  23. SavageR.L. HillG.R. BarnesJ. KenyonS.H. TatleyM.V. Suspected hepatotoxicity with a supercritical carbon dioxide extract of Artemisia annua in grapeseed oil used in New Zealand.Front. Pharmacol.201910144810.3389/fphar.2019.0144831920644
     [Google Scholar]
  24. AvontoC. RuaD. LasonkarP.B. ChittiboyinaA.G. KhanI.A. Identification of a compound isolated from German chamomile (Matricaria chamomilla) with dermal sensitization potential. Toxicol. Appl. Pharmacol., 2017, 318, 16-22.10.1016/j.taap.2017.01.00928109818
  25. AbdallaY.O.A. NyamathullaS. ShamsuddinN. ArshadN.M. MunK.S. AwangK. NagoorN.H. Acute and 28-day sub-acute intravenous toxicity studies of 1′-S-1′-acetoxychavicol acetate in rats.Toxicol. Appl. Pharmacol.201835620421310.1016/j.taap.2018.08.01430138658
     [Google Scholar]
  26. MinciulloP.L. CalapaiG. MiroddiM. MannucciC. ChinouI. GangemiS. SchmidtR.J. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - part 4: Solidago virgaurea-Vitis vinifera.Contact Dermat.2017772678710.1111/cod.1280728543097
     [Google Scholar]
  27. GariM. MajheeL. KumariK. Herbal drug-induced adverse drug reaction: a case report.Asian J. Pharm. Clin. Res., 2018, 11(2), 9-11.10.22159/ajpcr.2018.v11i2.22208
     [Google Scholar]
  28. MertzP. Lebrun-VignesB. SalemJ.E. ArnaudL. Characterizing drug-induced capillary leak syndromes using the World Health Organization VigiBase.J. Allergy Clin. Immunol.2019143143343610.1016/j.jaci.2018.09.00130244023
     [Google Scholar]
  29. XuY. PatelD.N. NgS.P. TanS.H. TohD. PohJ. LimA.T. ChanC.L. LowM.Y. KohH.L. Retrospective study of reported adverse events due to complementary health products in singapore from 2010 to 2016.Front. Med. (Lausanne)2018516710.3389/fmed.2018.0016729946545
     [Google Scholar]
  30. PaudyalB. ThapaA. SigdelK.R. AdhikariS. BasnyatB. Adverse events with ayurvedic medicines- possible adulteration and some inherent toxicities.Wellcome Open Res.201942310.12688/wellcomeopenres.15096.331641694
     [Google Scholar]
  31. ChangS.H. SongY.K. NahS.S. The clinical efficacy and safety of gumiganghwal-tang in knee osteoarthritis: A phase II randomized double blind placebo controlled study.Evid. Based Complement. Alternat. Med.20182018316512510.1155/2018/316512530538759
     [Google Scholar]
  32. LiaJ. OlleyeaO.E. YuX. High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care.Acta Pharmaceutica Sinica B, 2019, 9(5), 1035-1049.10.1016/j.apsb.2019.06.003
     [Google Scholar]
  33. AwortweC. MakiwaneM. ReuterH. MullerC. LouwJ. RosenkranzB. Critical evaluation of causality assessment of herb-drug interactions in patients.Br. J. Clin. Pharmacol.201884467969310.1111/bcp.1349029363155
     [Google Scholar]
  34. European Medicine Agency. Product-information templates2020Available at: https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/product-information/product-information-templates(Accessed on January 1, 2020).
     [Google Scholar]
  35. CostaJ.G. VidovicB. SaraivaN. do Céu CostaM. Del FaveroG. MarkoD. OliveiraN.G. FernandesA.S. Contaminants: A dark side of food supplements?Free Radic. Res.201953Suppl. 11113113510.1080/10715762.2019.163604531500469
    [Google Scholar]
/content/journals/cnt/10.2174/2665978601999200702163914
Loading
Adverse Effects of Natural Products: A Brief Pre-Systematic Review
Current Nutraceuticals 2, 14 (2021); https://doi.org/10.2174/2665978601999200702163914
/content/journals/cnt/10.2174/2665978601999200702163914
/content/journals/cnt/10.2174/2665978601999200702163914
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): adverse drug reaction; adverse effect; bioactive compounds; Natural products; patients' safety

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test